Ukucoceka okuphezulu kwe-USP EP 15663-27-1 Cisplatin yoNyango lokulwa nomhlaza
Imvelisoigama | Cisplatin |
Izithethantonye | cis-Diaminedichloroplatinum(II) |
Inombolo yeCAS. | 15663-27-1 |
Imbonakalo | Iikristale ezityheli okanye eziorenji zomgubo |
Ifomula yeemolekyuli | Cl2H6N2Pt |
Ubunzima beMolekyuli | 300.05 |
Ukusetyenziswa | IBanga lezamayeza okanye injongo yoPhando |
Ukupakisha | Ngokwesicelo sakho |
Ugcino | Londoloza kwizikhongozeli eziqinile, ezikwaziyo ukumelana nokukhanya kwindawo epholileyo |
Cisplatin I-CAS:15663-27-1 | ||
IZINTO | IMIGANGATHO | IZIPHUMO |
Imbonakalo | Iikristale ezityheli okanye eziorenji zomgubo | Iikristale zomgubo ezityheli |
Spectrum | HPLCIR TLC | IyahambelanaIyahambelana Iyahambelana |
Umlinganiselo wobunyulu be-UV | ≥4.5 | 5.2 |
Umda we-trichloroammin-eplatinate | ≤1.0% | 0.01% |
Umda we-transplatin | ≤2.0% | ND |
Umxholo wePlatinam | 64.42%~65.22% | 65.06% |
Amanzi | ≤1.0% | 0.10% |
Isivavanyi(Ibalwe ngokwesiseko se-anhydrous) | 98.0%~102.0% | 99.8% |
Iintsholongwane ze-Endotoxins | ≤2.0EU/mg | Iyahambelana |
Isiphelo:Ithobela umgangatho we-USP. |
Ulwazi lweNkampani
√ Amava apheleleyo omaleko wolawulo kumzi-mveliso kunye namagcisa anezakhono abalandeli; √ Umgangatho usoloko uyingqwalasela yethu ephezulu, inkqubo yeQC eQinisekileyo; √ Iminyaka eli-11 yamava eqela lokuthengisa kumazwe angaphandle; √ ilebhu yeR&D eZimeleyo; √ Iindibano zocweyo zeGMP ezimbini ezityikityiweyo zexesha elide; √ Imithombo etyebileyo yeefektri ezininzi ezingasebenziyo ukulungiselela iprojekthi elungelelanisiweyo; √ Iqela elisebenzayo eliSebenzayo ngokuSebenzayo ngendlela engaguqukiyo.Bhala umyalezo wakho apha kwaye uwuthumele kuthi